US Patent Issued to Terns Pharmaceuticals on Sept. 9 for "Compounds as GLP-IR agonists" (California Inventors)

ALEXANDRIA, Va., Sept. 10 -- United States Patent no. 12,410,163, issued on Sept. 9, was assigned to Terns Pharmaceuticals Inc..

"Compounds as GLP-IR agonists" was invented by Corey Reeves (Foster City, Calif.), Christopher T. Jones (Foster City, Calif.), Kevin Quinn (Foster City, Calif.) and Gary W. Luehr (Foster City, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present application provides compounds that may be used as a glucagon-like peptide-1 receptors (GLP-1R) agonist, or pharmaceutically acceptable salts thereof. Also provided are pharmaceutical compositions containing such compounds, or pharmaceutically acceptable salts thereof. Methods of preparing these compounds and compositions, and ...